Intuitive Surgical, Inc. $ISRG Shares Sold by Choreo LLC

Choreo LLC decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.6% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,158 shares of the medical equipment provider’s stock after selling 1,183 shares during the period. Choreo LLC’s holdings in Intuitive Surgical were worth $4,990,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Tobam grew its position in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC acquired a new stake in shares of Intuitive Surgical during the 2nd quarter valued at approximately $27,000. Greykasell Wealth Strategies Inc. bought a new position in Intuitive Surgical during the third quarter worth $27,000. Guerra Advisors Inc acquired a new position in Intuitive Surgical in the third quarter worth $37,000. Finally, Riggs Asset Managment Co. Inc. increased its stake in Intuitive Surgical by 84.2% during the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after purchasing an additional 32 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Down 0.7%

Shares of NASDAQ ISRG opened at $503.51 on Friday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The company has a market cap of $178.81 billion, a PE ratio of 63.82, a P/E/G ratio of 3.91 and a beta of 1.65. The stock has a 50 day simple moving average of $529.83 and a 200-day simple moving average of $511.48.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the previous year, the business earned $2.21 EPS. The firm’s revenue for the quarter was up 18.8% on a year-over-year basis. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ISRG. Barclays set a $712.00 price target on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research report on Monday, January 26th. TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. Raymond James Financial upped their target price on Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Sanford C. Bernstein raised their price target on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. Finally, Royal Bank Of Canada boosted their price objective on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday, December 17th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $615.86.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the sale, the executive vice president directly owned 409 shares in the company, valued at approximately $202,438.64. The trade was a 50.72% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $499.71, for a total transaction of $109,936.20. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 56,409 shares of company stock valued at $30,895,377. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.